Protagonist Therapeutics, Inc 8-K

What Happened
Protagonist Therapeutics, Inc. announced and furnished a press release reporting its financial results for the quarter ended March 31, 2026. The company filed Form 8‑K on May 5, 2026, to make the May 5, 2026 press release titled “Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update” publicly available.

Key Details

• Filing date: May 5, 2026 (Form 8‑K, Item 2.02).
• Reporting period: quarter ended March 31, 2026.
• Exhibit included: 99.1 — the May 5, 2026 press release; Exhibit 104 — Cover Page Interactive Data File (Inline XBRL).
• The furnished information and exhibit are explicitly stated as “furnished” (not “filed”) and therefore are not subject to certain liability provisions under the securities laws.

Why It Matters
This 8‑K gives investors timely access to Protagonist’s quarterly earnings and a corporate update, which may include key metrics such as revenue, expenses, cash position, and program progress (see the press release for details). Because the information is furnished rather than filed, it’s available for immediate review but formal liability protections differ from filed disclosures. Investors should read the press release and monitor upcoming periodic filings (e.g., the company’s 10‑Q) for comprehensive, detailed financial statements and reconciliations.